Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients.
Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink?
Perceptions of using videogames in rehabilitation: a dual perspective of people with multiple sclerosis and physiotherapists.
Direct visualization of membrane architecture of myelinating cells in transgenic mice expressing membrane-anchored EGFP.
The First Sphingosine 1-Phosphate Lyase Inhibitors against Multiple Sclerosis: A Successful Drug Discovery Tale.
Fatigue in multiple sclerosis: The contribution of occult white matter damage.
IL-17A and multiple sclerosis: signaling pathways, producing cells and target cells in the central nervous system.
Unusual Presentation of Unilateral Isolated Probable Lyme Optic Neuritis.
Repair strategies for multiple sclerosis: challenges, achievements and perspectives.
[The Effect of the Disease Duration on the Changes of the Visual Evoked Potentials and Contrast Sensitivity in Multiple Sclerosis].
Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17.
[Vitamin D in Multiple Sclerosis].
Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro.
Electrophysiological Evaluation of Dysphagia in the Mild or Moderate Patients with Multiple Sclerosis: A Concept of Subclinical Dysphagia.
Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis.
Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination.
[Pathogenesis of chronic inflammatory demyelinating polyneuropathy].
Similarities between Inherited Demyelinating Neuropathies and Wallerian Degeneration: An Old Repair Program May Cause Myelin and Axon Perturbation under Nonlesion Conditions.
IFNγ Influences Type I Interferon Response and Susceptibility to Theiler's Virus-Induced Demyelinating Disease.
Multiple Sclerosis in the Levant: A Regional Consensus Statement.
Epigenetics and the Modulation of Neuroinflammation.
[Assessment of the influence of rehabilitation in patients treated in a hospital rehabilitation ward due to consequences of neurological diseases].
Can multiple sclerosis as a cognitive disorder influence patients' dreams?
Everyday memory impairment, neuroradiological findings and physical disability in multiple sclerosis.
Efficacy and safety of fingolimod (FTY720) in patients with relapsing-remitting multiple sclerosis (FREEDOMS II)
Pages
« first
‹ previous
…
461
462
463
464
465
466
467
468
469
…
next ›
last »